BIOMAT Database Logo BIOMAT Database Logo

[Plasmapheresis in myasthenia gravis]. 1981

W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik

UI MeSH Term Description Entries
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011729 Pyridostigmine Bromide A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. Mestinon,Pyridostigmine,Bromide, Pyridostigmine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014797 Vital Capacity The volume of air that is exhaled by a maximal expiration following a maximal inspiration. Forced Vital Capacity,Capacities, Forced Vital,Capacities, Vital,Capacity, Forced Vital,Capacity, Vital,Forced Vital Capacities,Vital Capacities,Vital Capacities, Forced,Vital Capacity, Forced

Related Publications

W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
Plasmapheresis in myasthenia gravis.
January 1987, Annals of the New York Academy of Sciences,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
Plasmapheresis in myasthenia gravis.
January 1982, Progress in clinical and biological research,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
[Plasmapheresis in myasthenia gravis].
March 1986, Medicina clinica,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
Plasmapheresis in myasthenia gravis.
October 1981, Annals of neurology,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
[Plasmapheresis for myasthenia gravis].
February 1978, The New England journal of medicine,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
Plasmapheresis and myasthenia gravis.
January 1978, British medical journal,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
Plasmapheresis for myasthenia gravis.
July 1979, The Medical letter on drugs and therapeutics,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
Plasmapheresis therapy in myasthenia gravis.
January 1980, Muscle & nerve,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
Prethymectomy plasmapheresis in myasthenia gravis.
December 2005, Journal of clinical apheresis,
W O Jauregui, and C Di Gressia, and M E Herrera, and S Muchnik
[Plasmapheresis therapy of myasthenia gravis].
January 1992, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!